Application of Computational Methods for the Design of BACE-1 Inhibitors: Validation of in Silico Modelling

被引:17
作者
Bajda, Marek [1 ,2 ]
Jonczyk, Jakub [2 ]
Malawska, Barbara [2 ]
Filipek, Slawomir [1 ]
机构
[1] Univ Warsaw, Fac Chem, PL-02093 Warsaw, Poland
[2] Jagiellonian Univ, Dept Physicochem Drug Anal, Coll Med, Fac Pharm, PL-30688 Krakow, Poland
关键词
-secretase; BACE-1; inhibitor; molecular modelling; docking studies; validation; ALZHEIMERS-DISEASE; BETA-SECRETASE; THERAPEUTIC TARGET; CELL BIOLOGY; PART; 2ND-GENERATION; IDENTIFICATION; DISCOVERY; DERIVATIVES; SITE;
D O I
10.3390/ijms15035128
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
-Secretase (BACE-1) constitutes an important target for search of anti-Alzheimer's drugs. The first inhibitors of this enzyme were peptidic compounds with high molecular weight and low bioavailability. Therefore, the search for new efficient non-peptidic inhibitors has been undertaken by many scientific groups. We started our work from the development of in silico methodology for the design of novel BACE-1 ligands. It was validated on the basis of crystal structures of complexes with inhibitors, redocking, cross-docking and training/test sets of reference ligands. The presented procedure of assessment of the novel compounds as -secretase inhibitors could be widely used in the design process.
引用
收藏
页码:5128 / 5139
页数:12
相关论文
共 47 条
[1]
[Anonymous], 2009, 200910 MOE CHEM COMP
[2]
[Anonymous], 2006, PYMOL 0 99RC6
[3]
[Anonymous], 2010, SYBYL X 1 2
[4]
[Anonymous], 2011, GOLD 5 1
[5]
α-Naphthylaminopropan-2-ol Derivatives as BACE1 Inhibitors [J].
Asso, Valentina ;
Ghilardi, Elisa ;
Bertini, Simone ;
Digiacomo, Maria ;
Granchi, Carlotta ;
Minutolo, Filippo ;
Rapposelli, Simona ;
Bortolato, Andrea ;
Moro, Stefano ;
Macchia, Marco .
CHEMMEDCHEM, 2008, 3 (10) :1530-1534
[6]
Multi-Target-Directed Ligands in Alzheimer's Disease Treatment [J].
Bajda, M. ;
Guzior, N. ;
Ignasik, M. ;
Malawska, B. .
CURRENT MEDICINAL CHEMISTRY, 2011, 18 (32) :4949-4975
[7]
Conformational transition in the substrate binding domain of β-secretase exploited by NMA and its implication in inhibitor recognition: BACE1-myricetin a case study [J].
Chakraborty, Sandipan ;
Kumar, Sanjay ;
Basu, Soumalee .
NEUROCHEMISTRY INTERNATIONAL, 2011, 58 (08) :914-923
[8]
Second generation of BACE-1 inhibitors part 3: Towards non hydroxyethylamine transition state mimetics [J].
Charrier, Nicolas ;
Clarke, Brian ;
Cutler, Leanne ;
Demont, Emmanuel ;
Dingwall, Colin ;
Dunsdon, Rachel ;
Hawkins, Julie ;
Howes, Colin ;
Hubbard, Julia ;
Hussain, Ishrut ;
Maile, Graham ;
Matico, Rosalie ;
Mosley, Julie ;
Naylor, Alan ;
O'Brien, Alistair ;
Redshaw, Sally ;
Rowland, Paul ;
Soleil, Virginie ;
Smith, Kathrine J. ;
Sweitzer, Sharon ;
Theobald, Pam ;
Vesey, David ;
Walter, Daryl S. ;
Wayne, Gareth .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (13) :3674-3678
[9]
Second generation of BACE-1 inhibitors. Part 1: The need for improved pharmacokinetics [J].
Charrier, Nicolas ;
Clarke, Brian ;
Cutler, Leanne ;
Demont, Emmanuel ;
Dingwall, Colin ;
Dunsdon, Rachel ;
Hawkins, Julie ;
Howes, Colin ;
Hubbard, Julia ;
Hussain, Ishrut ;
Maile, Graham ;
Matico, Rosalie ;
Mosley, Julie ;
Naylor, Alan ;
O'Brien, Alistair ;
Redshaw, Sally ;
Rowland, Paul ;
Soleil, Virginie ;
Smith, Kathrine J. ;
Sweitzer, Sharon ;
Theobald, Pam ;
Vesey, David ;
Walter, Daryl S. ;
Wayne, Gareth .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (13) :3664-3668
[10]
Second generation of BACE-1 inhibitors part 2: Optimisation of the non-prime side substituent [J].
Charrier, Nicolas ;
Clarke, Brian ;
Demont, Emmanuel ;
Dingwall, Colin ;
Dunsdon, Rachel ;
Hawkins, Julie ;
Hubbard, Julia ;
Hussain, Ishrut ;
Maile, Graham ;
Matico, Rosalie ;
Mosley, Julie ;
Naylor, Alan ;
O'Brien, Alistair ;
Redshaw, Sally ;
Rowland, Paul ;
Soleil, Virginie ;
Smith, Kathrine J. ;
Sweitzer, Sharon ;
Theobald, Pam ;
Vesey, David ;
Walter, Daryl S. ;
Wayne, Gareth .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (13) :3669-3673